JP2011500592A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011500592A5 JP2011500592A5 JP2010529076A JP2010529076A JP2011500592A5 JP 2011500592 A5 JP2011500592 A5 JP 2011500592A5 JP 2010529076 A JP2010529076 A JP 2010529076A JP 2010529076 A JP2010529076 A JP 2010529076A JP 2011500592 A5 JP2011500592 A5 JP 2011500592A5
- Authority
- JP
- Japan
- Prior art keywords
- cmv
- vaccine
- cell type
- cell
- population
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000701022 Cytomegalovirus Species 0.000 claims 34
- 229960005486 vaccine Drugs 0.000 claims 18
- 210000004027 cell Anatomy 0.000 claims 16
- 238000000034 method Methods 0.000 claims 10
- 210000002919 epithelial cell Anatomy 0.000 claims 6
- 238000004113 cell culture Methods 0.000 claims 5
- 210000002950 fibroblast Anatomy 0.000 claims 5
- 230000001143 conditioned effect Effects 0.000 claims 4
- 210000002845 virion Anatomy 0.000 claims 4
- 230000002238 attenuated effect Effects 0.000 claims 2
- 230000036755 cellular response Effects 0.000 claims 2
- 210000004748 cultured cell Anatomy 0.000 claims 2
- 230000006698 induction Effects 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 241000700605 Viruses Species 0.000 claims 1
- 230000007910 cell fusion Effects 0.000 claims 1
- 210000000170 cell membrane Anatomy 0.000 claims 1
- 210000004443 dendritic cell Anatomy 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 210000002889 endothelial cell Anatomy 0.000 claims 1
- 230000004927 fusion Effects 0.000 claims 1
- 230000003053 immunization Effects 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 210000002540 macrophage Anatomy 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- 210000002569 neuron Anatomy 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 claims 1
- 210000002536 stromal cell Anatomy 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US99842607P | 2007-10-10 | 2007-10-10 | |
| US60/998,426 | 2007-10-10 | ||
| PCT/US2008/079494 WO2009049138A1 (en) | 2007-10-10 | 2008-10-10 | Cytomegalovirus vaccines and methods of production |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011500592A JP2011500592A (ja) | 2011-01-06 |
| JP2011500592A5 true JP2011500592A5 (enExample) | 2011-10-20 |
| JP5409638B2 JP5409638B2 (ja) | 2014-02-05 |
Family
ID=40549581
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010529076A Expired - Fee Related JP5409638B2 (ja) | 2007-10-10 | 2008-10-10 | サイトメガロウイルスワクチンおよび製造方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US9439960B2 (enExample) |
| EP (1) | EP2200645B1 (enExample) |
| JP (1) | JP5409638B2 (enExample) |
| KR (1) | KR20100084627A (enExample) |
| CN (1) | CN101820906B (enExample) |
| AU (1) | AU2008310713B2 (enExample) |
| BR (1) | BRPI0818656A2 (enExample) |
| CA (1) | CA2701727C (enExample) |
| IL (1) | IL204850A0 (enExample) |
| MX (1) | MX2010003713A (enExample) |
| NZ (1) | NZ584459A (enExample) |
| RU (1) | RU2491340C2 (enExample) |
| SG (1) | SG185291A1 (enExample) |
| WO (1) | WO2009049138A1 (enExample) |
| ZA (1) | ZA201002216B (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9439960B2 (en) | 2007-10-10 | 2016-09-13 | The Trustees Of Princeton University | Cytomegalovirus vaccines and methods of production |
| US8580276B2 (en) | 2009-06-05 | 2013-11-12 | City Of Hope | Genetically stable recombinant modified vaccinia ankara (rMVA) vaccines and methods of preparation thereof |
| TWI570240B (zh) | 2011-09-09 | 2017-02-11 | 默沙東公司 | 作為細胞巨大病毒疫苗之條件式複製ｃｍｖ |
| KR102146340B1 (ko) | 2012-03-27 | 2020-08-24 | 배리에이션 바이오테크놀로지스 아이엔씨. | 항-사이토메갈로바이러스 중화 항체를 탐지하기 위한 방법 |
| AU2013286093B2 (en) | 2012-07-06 | 2018-01-04 | Novartis Ag | Complexes of cytomegalovirus proteins |
| CA2879577C (en) * | 2012-07-27 | 2021-08-03 | City Of Hope | An mva vaccine for delivery of a ul128 complex and preventing cmv infection |
| US9395369B2 (en) | 2012-10-19 | 2016-07-19 | Regents Of The University Of Minnesota | Guinea pig cytomegalovirus (CIDMTR strain) |
| CN103937871B (zh) * | 2013-01-23 | 2019-07-23 | 上海市东方医院 | Srrp35基因和表达产物在癌症诊断与治疗中的应用 |
| EP3068431A4 (en) * | 2013-11-15 | 2017-08-23 | President and Fellows of Harvard College | Methods and compositions for the treatment of hcmv |
| US10611800B2 (en) | 2016-03-11 | 2020-04-07 | Pfizer Inc. | Human cytomegalovirus gB polypeptide |
| WO2018183426A1 (en) * | 2017-03-30 | 2018-10-04 | Merck Sharp & Dohme Corp. | Addition of nucleases directly to cell culture to facilitate digestion and clearance of host cell nucleic acids |
| EP3612550B1 (en) * | 2017-04-19 | 2025-06-18 | GlaxoSmithKline Biologicals S.A. | Modified cytomegalovirus proteins and stabilized complexes |
| CN111344397A (zh) * | 2017-11-01 | 2020-06-26 | 默沙东公司 | 巨细胞病毒的稳定制剂 |
| US11629172B2 (en) | 2018-12-21 | 2023-04-18 | Pfizer Inc. | Human cytomegalovirus gB polypeptide |
| TWI871709B (zh) | 2020-06-21 | 2025-02-01 | 美商輝瑞股份有限公司 | 人巨細胞病毒糖蛋白Ｂ（ｇＢ）多肽 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3959466A (en) * | 1974-04-15 | 1976-05-25 | The Wistar Institute | Highly attenuated cytomegalovirus vaccine and production thereof |
| US4058598A (en) * | 1974-10-18 | 1977-11-15 | Harold Stern | Cytomegalovirus attenuation method and vaccine |
| US6471965B1 (en) * | 1994-07-27 | 2002-10-29 | Bio-Virus Research Incorporated | Vaccine containing whole killed herpes viruses to prevent development of atherosclerotic plaque |
| DE10144906B4 (de) * | 2001-09-12 | 2013-11-28 | Novartis Vaccines And Diagnostics Gmbh | Verfahren zur großtechnischen Herstellung von Impfstoffen |
| US7407744B2 (en) * | 2003-07-25 | 2008-08-05 | The Regents Of The University Of California | Cytomegalovirus gene function and methods for developing antivirals, anti-CMV vaccines, and CMV-based vectors |
| US7704510B2 (en) * | 2006-06-07 | 2010-04-27 | The Trustees Of Princeton University | Cytomegalovirus surface protein complex for use in vaccines and as a drug target |
| US9439960B2 (en) | 2007-10-10 | 2016-09-13 | The Trustees Of Princeton University | Cytomegalovirus vaccines and methods of production |
-
2008
- 2008-10-01 US US12/681,504 patent/US9439960B2/en active Active
- 2008-10-10 NZ NZ584459A patent/NZ584459A/en not_active IP Right Cessation
- 2008-10-10 AU AU2008310713A patent/AU2008310713B2/en not_active Ceased
- 2008-10-10 SG SG2012075594A patent/SG185291A1/en unknown
- 2008-10-10 BR BRPI0818656-1A patent/BRPI0818656A2/pt not_active IP Right Cessation
- 2008-10-10 CN CN200880111084.9A patent/CN101820906B/zh not_active Expired - Fee Related
- 2008-10-10 JP JP2010529076A patent/JP5409638B2/ja not_active Expired - Fee Related
- 2008-10-10 EP EP08836810.5A patent/EP2200645B1/en active Active
- 2008-10-10 MX MX2010003713A patent/MX2010003713A/es active IP Right Grant
- 2008-10-10 CA CA2701727A patent/CA2701727C/en active Active
- 2008-10-10 RU RU2010117741/10A patent/RU2491340C2/ru not_active IP Right Cessation
- 2008-10-10 KR KR1020107008187A patent/KR20100084627A/ko not_active Withdrawn
- 2008-10-10 WO PCT/US2008/079494 patent/WO2009049138A1/en not_active Ceased
-
2010
- 2010-03-29 ZA ZA2010/02216A patent/ZA201002216B/en unknown
- 2010-04-06 IL IL204850A patent/IL204850A0/en unknown
-
2016
- 2016-07-29 US US15/223,980 patent/US10300130B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108486108B (zh) | 一种敲除人hmgb1基因的细胞株及其应用 | |
| RU2010117741A (ru) | Вакцина против цитомегаловируса и способ ее получения | |
| JP2006527995A (ja) | 付着または非付着の鳥類細胞系を用いた、ポックスウィルスの作製法 | |
| JP2013533745A5 (enExample) | ||
| US20220389391A1 (en) | F-genotype mumps virus attenuated strain and construction method therefor and application thereof | |
| JP2010506586A5 (enExample) | ||
| CN119351466B (zh) | 一株弓形虫基因敲除疫苗虫株的构建方法及其应用 | |
| CN102210861A (zh) | 丙型肝炎病毒多表位肽负荷的树突状细胞治疗性疫苗 | |
| US20250051787A1 (en) | Method for gene expression by transient transformation of wild rice seed using agrobacterium | |
| CN104178459A (zh) | 一种无血清悬浮培养狂犬病毒的方法 | |
| RU2494106C2 (ru) | Гены, кодирующие главный капсидный белок l1 вируса папилломы человека, и их применение | |
| CN114990075B (zh) | 一株可适用于人用疫苗细胞基质培养的柯萨奇病毒a组10型疫苗株及其应用 | |
| CN104894054B (zh) | 一种猴胚胎肾上皮细胞Marc‑145悬浮适应株及其在培养蓝耳病病毒、生产蓝耳病毒疫苗中的应用 | |
| CN113151171B (zh) | 猪肺泡巨噬细胞健康细胞系及构建方法与应用 | |
| CN121628844A (zh) | 一种古尔图病毒减毒株及其应用 | |
| CN120290323A (zh) | 一种Tgsrs51基因缺失的弓形虫减毒虫株及其应用 | |
| CN110643520A (zh) | 高产南极紫红色素的南极真菌Geomyces sp.突变株及其应用 | |
| CN110423782A (zh) | 一株Marc-145稳定细胞株的构建及应用 | |
| CN113583980A (zh) | 一种猪繁殖与呼吸综合征突变病毒及其构建方法与应用 | |
| CN102911920A (zh) | Ⅱ型登革病毒kmb17细胞适应株及其制备方法 | |
| CN103992962A (zh) | 变异链球菌rnc基因突变株及其应用 | |
| Marcelino et al. | Characterization of Ehrlichia ruminantium replication and release kinetics in endothelial cell cultures | |
| CN104087549B (zh) | 高产杆状病毒的昆虫细胞系及其应用 | |
| CN107058247B (zh) | 高保真猪繁殖与呼吸综合症病毒弱毒株及其应用 | |
| CN118460584A (zh) | 基于CRISPR-Cas9系统的营养缺陷型乳酸菌基因编辑系统及应用 |